Both in Pharmaceuticals
Perspective Therapeutics vs OnKure Therapeutics
Over the past year CATX returned −62.7% and OKUR returned −16.5%; their daily moves had a correlation of 0.08.
CATX −62.7% OKUR −16.5%Growth of $1, one year, split-adjusted
| Metric | CATX | OKUR |
|---|---|---|
| Price | $0.8702 | $2.59 |
| Market cap | $99.3M | $104.9M |
| Today | −1.11% | +3.60% |
| 1 month | −63.1% | +5.3% |
| 6 months | −77.2% | −36.4% |
| Year to date | −68.4% | −10.7% |
| 1 year | −66.5% | −20.8% |
| Revenue growth (YoY) | −72.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −33069.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 242.9× | — |
| Net cash | $235.3M | $176.4M |
| Dividend yield | — | — |
| Volatility (60d) | 117.1% | 56.2% |
| Short % of float | 17.1% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).